Cargando…

Recombinant human activated factor VII in postpartum hemorrhagic shock: the dark side

Detalles Bibliográficos
Autores principales:	van Veen, E. J. W., Monteban-Kooistra, W. E., Meertens, J. H. J. M., Ligtenberg, J. J. M., Tulleken, J. E., Zijlstra, J. G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2007
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227034/ https://www.ncbi.nlm.nih.gov/pubmed/17668176 http://dx.doi.org/10.1007/s00134-007-0810-0

Ejemplares similares

Comment on Mackenzie and Woodhouse: C-reactive protein concentrations during bacteraemia: a comparison between patients with and without liver dysfunction
por: Droogh, Joep M., et al.
Publicado: (2007)

Recombinant Activated Factor VII as a Second Line Treatment for Postpartum Hemorrhage
por: Park, Soon Chang, et al.
Publicado: (2017)

Towards a feasible algorithm for tight glycaemic control in critically ill patients: a systematic review of the literature
por: Meijering, Sofie, et al.
Publicado: (2006)

Subcutaneous glucose measurements and glucose regulation (?)
por: Ligtenberg, Jack J., et al.
Publicado: (2010)

Quality of interhospital transport of critically ill patients: a prospective audit
por: Ligtenberg, Jack JM, et al.
Publicado: (2005)

High mortality rate in critically ill medical patients with new-onset atrial tachyarrhythmias despite rapid conversion to sinus rhythm
por: Sleeswijk, M, et al.
Publicado: (2005)

Bakri balloon tamponade to treat postpartum hemorrhage
por: Yang, Hui, et al.
Publicado: (2022)

Postpartum Hemorrhage
por: Grosvenor, J. W.
Publicado: (1904)

Treatment of obstetric hemorrhage with recombinant activated factor VII
por: Czuprynski, P, et al.
Publicado: (2009)

Guidelines-associated decrease in mortality with recombinant activated factor VII for refractory hemorrhage
por: Schneider, AS, et al.
Publicado: (2009)

Antipsychotic-induced catatonia and neuroleptic malignant syndrome: the dark side of the moon
por: Hirjak, Dusan, et al.
Publicado: (2021)

Accuracy and feasibility of point-of-care and continuous blood glucose analysis in critically ill ICU patients
por: Corstjens, Anouk M, et al.
Publicado: (2006)

Can we afford open-ended ICU care? Yes we can, but ...
por: Arnold, Klaas-Sierk, et al.
Publicado: (2010)

Recombinant activated factor VII for diffuse alveolar hemorrhage in microscopic polyangiitis
por: Mandal, S. K., et al.
Publicado: (2012)

The Heart on the Right Side
por: Fleming, J. G. S.
Publicado: (1919)

Research Letter: Is neuroticism a risk factor for postpartum depression?
por: MARTÍN-SANTOS, R., et al.
Publicado: (2012)

Uncovering The Dark Side Of Covid 19 On Nutrition Therapy
por: Demol, J., et al.
Publicado: (2023)

Recombinant activated factor VII in cardiac surgery – first, do no harm
por: Warren, Oliver J, et al.
Publicado: (2007)

Is Postpartum Psychosis Incidence Increasing During the COVID-19 Pandemic?
por: Jansen, Madeline O., et al.
Publicado: (2021)

Successful pulmonary administration of activated recombinant factor VII in diffuse alveolar hemorrhage
por: Heslet, Lars, et al.
Publicado: (2006)

Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage
por: Aggarwal, Anita, et al.
Publicado: (2004)

Life-threatening hemorrhage in neonates and children: treatment with activated recombinant factor VII
por: Fischer, D, et al.
Publicado: (2003)

Recombinant activated factor VII in a patient with intracranial hemorrhage and severe thrombocytopenia
por: Ansari, Amir M., et al.
Publicado: (2021)

The Dark Side of hormone prescription
por: Auchus, Richard J
Publicado: (2021)

Methylglyoxal, the dark side of glycolysis
por: Allaman, Igor, et al.
Publicado: (2015)

Efficacy of recombinant activated factor VII in the management of severe hemorrhage following cardiac surgery
por: Trecova, N, et al.
Publicado: (2006)

Anaphylactic Shock after Milk Injection
por: Paul, J. N.
Publicado: (1930)

Response to Tomao, Panici, and Tomao
por: Vos, Janet R, et al.
Publicado: (2019)

Clinical review: Treatment of new-onset atrial fibrillation in medical intensive care patients: a clinical framework
por: Sleeswijk, Mengalvio E, et al.
Publicado: (2007)

Effect of anakinra in COVID-19
por: Kooistra, Emma J, et al.
Publicado: (2020)

Value and price of ventilator-associated pneumonia surveillance as a quality indicator
por: Aardema, Heleen, et al.
Publicado: (2010)

Efficacy of recombinant activated factor VII (rFVIIa; NovoSeven(®)) in obstetrical haemorrhagic shock
por: Sobieszczyk, S, et al.
Publicado: (2003)

Advantage of using a recombinant activated factor VII in traumatic haemorrhagic shock: The Bordeaux experience
por: Morel, Nicolas, et al.
Publicado: (2012)

Failure of Recombinant Activated Factor VII in Treatment of Diffuse Alveolar Hemorrhage due to Cryoglobulinemic Vasculitis
por: Khoulani, Dania, et al.
Publicado: (2014)

Successful hemostasis in refractory alveolar hemorrhage using low-dose recombinant activated factor VII
por: Selickman, John, et al.
Publicado: (2022)

Why Are We One-Sided?
por: Nunan, W.
Publicado: (1928)

The Dark Side of Dysphagia: Esophageal Melanocytosis
por: Mir, Adil S., et al.
Publicado: (2019)

Hyperglycaemia in critically ill patients: marker or mediator of mortality?
por: Corstjens, Anouk M, et al.
Publicado: (2006)

Safety of activated recombinant factor VII in patients with circulatory assist devices
por: Schneider, AS, et al.
Publicado: (2009)

On the Dark Side of Therapies with Immunoglobulin Concentrates: The Adverse Events
por: Späth, Peter J., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5bdj49vbjbcdbd18c8r3u0igmp